Company Valuation: Pfizer Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 198,918 158,614 191,909 183,197 215,952 208,925 -
Change - -20.26% 20.99% -4.54% 17.88% -3.25% -
Enterprise Value (EV) 198,918 158,614 191,909 183,197 215,952 208,925 208,925
Change - -20.26% 20.99% -4.54% 17.88% -3.25% 0%
P/E 32.5x 25.4x 34.8x 23.9x 29.9x 25.1x 22.5x
PBR 6.94x 4.95x 5.34x 4.34x 5.14x 4.4x 3.88x
PEG - 13.66x -3x 0.6x -5.08x 1.7x 1.9x
Capitalization / Revenue 7.62x 6.54x 8.75x 8.03x 8.57x 7.67x 7.01x
EV / Revenue 0x 0x 0x 0x 0x 7.67x 7.01x
EV / EBITDA 0x 0x 0x 0x 0x 21.7x 19.7x
EV / EBIT 0x 0x 0x 0x 0x 22x 19.9x
EV / FCF 0x 0x 0x 0x 0x 40.9x 31.9x
FCF Yield 4.19% 1.83% 1.24% 3.45% 4.36% 2.44% 3.13%
Dividend per Share 2 35 35 35 35 75 69.45 71.2
Rate of return 0.8% 1.01% 0.83% 0.87% 1.59% 1.52% 1.56%
EPS 2 133.9 136.4 120.5 167.8 157.9 181.8 203.1
Distribution rate 26.1% 25.7% 29% 20.9% 47.5% 38.2% 35.1%
Net sales 1 26,110 24,248 21,932 22,814 25,196 27,241 29,818
EBITDA 1 8,357 8,089 6,353 7,402 9,041 9,620 10,604
EBIT 1 7,207 7,034 5,730 6,794 8,464 9,512 10,512
Net income 1 6,126 6,239 5,513 7,676 7,224 8,315 9,292
Net Debt - - - - - - -
Reference price 2 4,348.15 3,467.15 4,194.95 4,004.50 4,720.50 4,566.90 4,566.90
Nbr of stocks (in thousands) 45,748 45,748 45,748 45,748 45,748 45,748 -
Announcement Date 20/05/22 15/05/23 17/05/24 19/05/25 12/05/26 - -
1INR in Million2INR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
25.13x - - 1.52% 2.17B
35.04x12.53x26.21x0.57% 1,051B
27.19x6.2x16.98x2.12% 609B
33.15x7.52x15.43x2.7% 450B
17.85x4.43x10.91x3% 330B
21.66x5.55x13.44x2.84% 284B
21.16x4.46x12.34x1.97% 263B
14.44x5.41x11.14x3.44% 223B
24.02x6.35x11.22x2.75% 198B
-48.37x5.78x31.95x2.42% 167B
Average 17.13x 6.47x 16.62x 2.33% 357.72B
Weighted average by Cap. 24.01x 7.82x 18.33x 2%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. PFIZER Stock
  4. Valuation Pfizer Limited